Published in Nature Genetics · View the paper (DOI)
Scientists have decoded the genome and transcriptome of an incurable subtype of acute lymphoblastic leukemia, revealing a novel program associated with leukemic cells. The study identifies key genes that trigger a reprogramming of the leukemia cells, leading to promising drug tests, including Venetoclax.
Coverage from 2 institutions
- New treatment options for a fatal leukemia University of Zurich · Jul 27, 2015 · first to report
- Basis for new treatment options for a fatal leukemia in children revealed MC Services AG · Jul 29, 2015